News & Views | Published:

Type 1 diabetes: focus on prevention

Nature Medicine volume 10, pages 783784 (2004) | Download Citation

Subjects

Two new approaches prevent disease in a model of type 1 diabetes. One approach blocks an activation receptor on disease-conferring T cells. The second deploys suppressor T cells renowned for their ability to inhibit the local immune response.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    et al. Immunity 20, 757–767 (2004).

  2. 2.

    et al. J. Exp. Med. 199, 1455–1465 (2004).

  3. 3.

    , , , & J. Exp. Med. 199, 1467–1477 (2004).

  4. 4.

    , , & Nat. Immunol. 4, 337–342 (2003).

  5. 5.

    , , , & J. Immunol. 155, 1151–1164 (1995).

  6. 6.

    et al. Eur. J. Immunol. 34, 623–630 (2004).

  7. 7.

    , & Nat. Immunol. 4, 330–336 (2003).

  8. 8.

    , & Science 299, 1057–1061 (2003).

  9. 9.

    et al. Nat Immunol. 2, 301–306 (2001).

  10. 10.

    , , & Nat. Immunol. 3, 756–763 (2002).

  11. 11.

    & J. Exp. Med. 199, 1401–1408 (2004).

  12. 12.

    J. Exp. Med. 198, 845–849 (2003).

  13. 13.

    Nat. Rev. Immunol. 2, 389–400 (2002).

  14. 14.

    , , & J. Exp. Med. 199, 1479–1489 (2004).

  15. 15.

    & Proc. Natl. Acad. Sci. USA 93, 956–960 (1996).

  16. 16.

    Diabetes Prevention Trial—Type 1 Diabetes Study Group. N. Engl. J. Med. 346, 1685–1691 (2002).

Download references

Author information

Affiliations

  1. Harald von Boehmer is at the Harvard Medical School, Dana-Farber Cancer Institute, 1 Jimmy Fund Way, Boston, Massachusetts, 02115, USA. Harald_von_Boehmer@dfci.harvard.edu

    • Harald von Boehmer

Authors

  1. Search for Harald von Boehmer in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nm0804-783

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing